Anemia Predicts Poor Outcomes in Patients with HBV-Related Decompensated Cirrhosis.

BACKGROUND

Anemia is common in patients with severe chronic liver disease, but its role in HBV-related decompensated cirrhosis (DeCi) is still unclear. We therefore aimed to assess the impact of anemia on prognosis in HBV-DeCi patients.

METHODS

One hundred thirty-three patients diagnosed with HBV-DeCi were retrospectively collected.

RESULTS

A total of 113 (85.0%) patients suffered from anemia in our cohort. The low hemoglobin (Hb) level group exhibited a significantly increased 28-day mortality rate compared with the high Hb group. Hb level was a predictor of 28-day mortality in HBV-DeCi patients.

CONCLUSIONS

Reduced Hb levels were associated with unfavorable prognosis in HBV-DeCi patients, and more attention should be paid to anemia in routine clinical assessments of liver cirrhosis.